Systematic review of trials using vasodilators in pulmonary arterial hypertension: Why a new approach is needed
- 1 February 2010
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 159 (2) , 245-257
- https://doi.org/10.1016/j.ahj.2009.11.028
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Tadalafil Therapy for Pulmonary Arterial HypertensionCirculation, 2009
- A meta-analysis of randomized controlled trials in pulmonary arterial hypertensionEuropean Heart Journal, 2008
- Ambrisentan for the Treatment of Pulmonary Arterial HypertensionCirculation, 2008
- Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary HypertensionCirculation, 2006
- Bosentan Therapy in Patients With Eisenmenger SyndromeCirculation, 2006
- A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertensionPublished by Elsevier ,2006
- Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial HypertensionCirculation, 2005
- Clinical efficacy of sildenafil in primary pulmonary hypertensionJournal of the American College of Cardiology, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 2001